Company: KVACU
Filing Date: 2025-03-07
Form Type: 10-K
Source: 0001213900-25-021314
Chunk: 1384

Company: Keen Vision Acquisition Corp.
Filing Date: 2025-03-07
Form: 10-K
Item: Item 14
Chunk 1384
---
 Public Accounting Firm (PCAOB ID: 3686)
    F-2
  
    Consolidated Balance Sheets
    F-3
  
    Consolidated Statements of Operations and Comprehensive Income 
    F-4
  
    Consolidated Statements of Changes in Shareholders’ Deficit
    F-5
  
    Consolidated Statements of Cash Flows
    F-6
  
    Notes to Consolidated Financial Statements
    F-7 – F-19

    (2)
    Financial Statement Schedules:

None.

    (3)
    Exhibits

We hereby file as part of
this Report the exhibits listed in the attached Exhibit Index. Exhibits which are incorporated herein by reference can be inspected on
the SEC website at www.sec.gov.

43

EXHIBIT INDEX

    Exhibit No.
     
    Description

    1.1
     
    Underwriting Agreement, dated July 24, 2023, by and between the Company and EF Hutton, division of Benchmark Investments, LLC. (incorporated by reference to Exhibit 1.1 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on July 27, 2023)

    2.1
     
    Merger Agreement dated September 3, 2024 (incorporated by reference to Exhibit 2.1 to Keen Vision’s Current Report on Form 8-K filed with the Securities and Exchange Commission on September 5, 2024)

    2.2*
     
    Joinder agreement to the Merger Agreement dated September 16, 2024

    3.1
     
    Amended and Restated Memorandum and Articles of Association (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on July 27, 2023)

    4.1
     
    Specimen Unit Certificate (incorporated by reference to Exhibit 4.1 to the Registration Statement on Form S-1/A filed with the Securities and Exchange Commission on July 10, 2023)

    4.2
     
    Specimen  Ordinary Share Certificate (incorporated by reference to Exhibit 4.2 to the Registration Statement on Form S-1/A filed with the Securities and Exchange Commission on July 10, 2023)

    4.3
     
    Specimen Warrant Certificate (incorpor